DNA-based delivery of anti-DR5 nanobodies improves exposure and anti-tumor efficacy over protein-based administration
Vermeire, Giles, De Smidt, Elien, Casteels, Peter, Geukens, Nick, Declerck, Paul, Hollevoet, KevinJournal:
Cancer Gene Therapy
DOI:
10.1038/s41417-020-0204-9
Date:
July, 2020
File:
PDF, 766 KB
2020